T. Rowe Price Associates’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-198,326
Closed -$3.44M 2931
2024
Q1
$3.44M Buy
198,326
+196,126
+8,915% +$3.48M ﹤0.01% 1336
2023
Q4
$29K Hold
2,200
﹤0.01% 2853
2023
Q3
$82K Sell
2,200
-865
-28% -$38.5K ﹤0.01% 2697
2023
Q2
$124K Buy
3,065
+70
+2% +$3.96K ﹤0.01% 2650
2023
Q1
$218K Sell
2,995
-258
-8% -$25K ﹤0.01% 2486
2022
Q4
$267K Sell
3,253
-1,025
-24% -$107K ﹤0.01% 2413
2022
Q3
$405K Buy
4,278
+2,513
+142% +$282K ﹤0.01% 2231
2022
Q2
$344K Buy
1,765
+618
+54% +$101K ﹤0.01% 2386
2022
Q1
$266K Buy
1,147
+247
+27% +$78.7K ﹤0.01% 2597
2021
Q4
$355K Sell
900
-469
-34% -$197K ﹤0.01% 2531
2021
Q3
$613K Buy
1,369
+8
+0.6% +$2.87K ﹤0.01% 2280
2021
Q2
$529K Buy
1,361
+195
+17% +$69.6K ﹤0.01% 2369
2021
Q1
$419K Buy
1,166
+13
+1% +$5.75K ﹤0.01% 2446
2020
Q4
$566K Buy
1,153
+564
+96% +$260K ﹤0.01% 2190
2020
Q3
$191K Buy
+589
New +$201K ﹤0.01% 2433
2019
Q3
Sell
-10,609
Closed -$5.33M 2521
2019
Q2
$5.33M Sell
10,609
-59,461
-85% -$42M ﹤0.01% 1388
2019
Q1
$69.6M Sell
70,070
-943
-1% -$876K 0.01% 742
2018
Q4
$61.7M Buy
71,013
+339
+0.5% +$315K 0.01% 746
2018
Q3
$73.1M Buy
70,674
+2,170
+3% +$2.12M 0.01% 773
2018
Q2
$62.9M Buy
68,504
+786
+1% +$844K 0.01% 800
2018
Q1
$66M Buy
+67,718
New +$61.7M 0.01% 776
2016
Q3
Sell
-1,070
Closed -$602K 2530
2016
Q2
$602K Buy
1,070
+606
+131% +$291K ﹤0.01% 1894
2016
Q1
$221K Hold
464
﹤0.01% 2269
2015
Q4
$306K Sell
464
-1,152
-71% -$871K ﹤0.01% 2147
2015
Q3
$1.27M Buy
+1,616
New +$1.97M ﹤0.01% 1640

Other funds holding ATRA